News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,270 Results
Type
Article (7117)
Company Profile (16)
Press Release (218137)
Section
Business (63111)
Career Advice (294)
Deals (14767)
Drug Delivery (27)
Drug Development (36766)
Employer Resources (24)
FDA (6404)
Job Trends (4906)
News (121763)
Policy (11619)
Tag
Academia (563)
Alliances (14730)
Alzheimer's disease (575)
Approvals (6421)
Artificial intelligence (80)
Bankruptcy (146)
Best Places to Work (4608)
Breast cancer (89)
Cancer (885)
Cardiovascular disease (52)
Career advice (257)
CAR-T (73)
Cell therapy (183)
Clinical research (30782)
Collaboration (247)
Compensation (66)
COVID-19 (712)
C-suite (55)
Data (999)
Diabetes (83)
Diagnostics (2195)
Earnings (32711)
Events (30514)
Executive appointments (183)
FDA (6889)
Funding (211)
Gene therapy (111)
GLP-1 (159)
Government (1247)
Healthcare (6131)
Infectious disease (760)
Inflammatory bowel disease (55)
Interviews (45)
IPO (8007)
Job creations (570)
Job search strategy (220)
Legal (2093)
Lung cancer (126)
Lymphoma (58)
Manufacturing (81)
Medical device (4542)
Medtech (4543)
Mergers & acquisitions (7025)
Metabolic disorders (215)
Neuroscience (723)
NextGen: Class of 2025 (1499)
Non-profit (710)
Northern California (1009)
Obesity (114)
Opinion (69)
Parkinson's disease (47)
Patents (91)
People (14359)
Phase I (9810)
Phase II (13553)
Phase III (10153)
Pipeline (455)
Postmarket research (796)
Preclinical (3551)
Radiopharmaceuticals (115)
Rare diseases (136)
Real estate (999)
Regulatory (8981)
Research institute (509)
Southern California (860)
Startups (675)
United States (8498)
Vaccines (143)
Weight loss (65)
Date
Last 7 days (244)
Last 30 days (1075)
Last 365 days (16486)
2025 (1946)
2024 (16924)
2023 (19103)
2022 (22236)
2021 (23634)
2020 (21800)
2019 (14442)
2018 (10640)
2017 (11455)
2016 (9542)
2015 (11738)
2014 (8102)
2013 (5877)
2012 (6040)
2011 (6751)
2010 (6216)
Location
Africa (175)
Asia (17405)
Australia (4818)
California (2250)
Canada (969)
China (181)
Colorado (98)
Connecticut (137)
Delaware (43)
Europe (27611)
Florida (324)
Georgia (51)
Illinois (168)
Indiana (101)
Japan (73)
Maryland (284)
Massachusetts (1653)
Michigan (48)
Minnesota (87)
New Jersey (792)
New York (728)
North Carolina (336)
Northern California (1009)
Ohio (51)
Pennsylvania (547)
South America (300)
Southern California (860)
Texas (329)
Utah (52)
Virginia (57)
Washington State (305)
225,270 Results for "bionomics limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Bionomics Limited Announces Private Placement of up to $70.0 Million
Bionomics Limited announced it has entered into a securities purchase agreement with an institutional accredited investor to purchase American Depository Shares and accompanying warrants in a three-tranche private placement.
May 31, 2024
·
7 min read
Press Releases
Bionomics Limited announces intention to re-domicile to the United States
October 1, 2024
·
9 min read
Press Releases
Bionomics to Present at the 2024 CNS Summit
November 8, 2024
·
3 min read
Genetown
Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
Bionomics Limited announced that Spyridon “Spyros” Papapetropoulos, M.D., PhD, President and Chief Executive Officer of Bionomics will be giving an oral presentation and presenting two posters about BNC210 as a potential treatment for social anxiety disorder and post-traumatic stress disorder at the 2024 American Society of Clinical Psychopharmacology Annual Meeting taking place May 28 – 31 in Miami Beach, Florida.
May 20, 2024
·
4 min read
Press Releases
Bionomics to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting
December 4, 2024
·
4 min read
Genetown
Bionomics to Present at the 2024 BIO CEO & Investor Conference
Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) today announced that it will be presenting at the 2024 BIO CEO & Investor Conference taking place February 26-27, 2024 in New York, NY.
February 22, 2024
·
3 min read
Press Releases
Bionomics Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision
October 7, 2024
·
8 min read
Genetown
Bionomics Provides a Review of 2023 and of 2024 Plans
Bionomics Limited, a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system disorders with high unmet medical need, provided a 2023 review and its outlook for 2024.
January 22, 2024
·
8 min read
Drug Development
Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder
Bionomics Limited announced the release of the full dataset analysis from its Phase 2b ATTUNE trial in patients with post-traumatic stress disorder.
March 21, 2024
·
10 min read
Press Releases
Bionomics Publishes the Positive Results from the Phase 2 ATTUNE Study of BNC210 in Patients with Post-Traumatic Stress Disorder in NEJM Evidence
December 9, 2024
·
5 min read
1 of 22,527
Next
